BENDAMUSTINE HYDROCHLORIDE is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is Bendamustine Hydrochloride.
| Product ID | 10019-079_132b5560-e803-4112-ae4c-c8c607e674c4 |
| NDC | 10019-079 |
| Product Type | Human Prescription Drug |
| Proprietary Name | BENDAMUSTINE HYDROCHLORIDE |
| Generic Name | Bendamustine Hydrochloride |
| Dosage Form | Injection |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2022-12-15 |
| Marketing Category | NDA / |
| Application Number | NDA216078 |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | BENDAMUSTINE HYDROCHLORIDE |
| Active Ingredient Strength | 100 mg/1 |
| Pharm Classes | Alkylating Activity [MoA], Alkylating Drug [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2022-12-15 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 10019-079 | BENDAMUSTINE HYDROCHLORIDE | bendamustine hydrochloride |
| 16729-250 | bendamustine hydrochloride | bendamustine hydrochloride |
| 16729-251 | bendamustine hydrochloride | bendamustine hydrochloride |
| 42367-520 | BENDAMUSTINE HYDROCHLORIDE | bendamustine hydrochloride |
| 42367-521 | BELRAPZO | bendamustine hydrochloride |
| 63459-348 | Bendeka | bendamustine hydrochloride |
| 63459-390 | TREANDA | Bendamustine Hydrochloride |
| 63459-391 | TREANDA | Bendamustine Hydrochloride |
| 71225-120 | VIVIMUSTA | BENDAMUSTINE HYDROCHLORIDE |